Cover Image
市場調查報告書

中國的Atorvastatin市場調查

Investigation Report on China Atorvastatin Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 296114
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Atorvastatin市場調查 Investigation Report on China Atorvastatin Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

雖然中國的血脂異常的盛行率比大部分的先進各國低,但是中國人的平均血中總膽固醇(TC)等級由於經濟發展和生活方式的變化而提高。另一方面,在中國中糖尿病和代謝症候群極為普遍。根據統計18歲以上年齡層的血脂異常盛行率的超越20%,患者總數超過2億人。Atorvastatin用於降低血中膽固醇。根據CRI的調查,中國的醫院市場上2005-2014年的Atorvastatin的年複合成長率超過40%。

本報告提供中國的Atorvastatin市場相關分析、主要廠商的市場佔有率、中國的醫院市場上價格變化、銷售額、主要企業,及市場展望等等,為您概述為以下內容。

第1章 Atorvastatin相關的概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國的Atorvastatin的市場概要

  • 專利情形
  • 主要製造商
  • 市場規模

第3章 中國的Atorvastatin的銷售額調查

  • 銷售額
    • 整體銷售額
    • 各地區
  • 銷售量
    • 整體銷售量
    • 各地區

第4章 中國的主要Atorvastatin製造商市場佔有率調查

  • 市場佔有率:各銷售額
  • 市場佔有率:各銷售額

第5章 Atorvastatin的市場規模調查:中國的各投藥形態

  • 市場佔有率:各銷售額、投藥形態
  • 市場佔有率:各銷售額、投藥形態

第6章 中國的醫院市場上Atorvastatin的標準價格

  • Beijing Jialin Pharmaceutical Co., Ltd.製造的Atorvastatin價格
  • Topfond 製造的Atorvastatin價格
  • Pfizer Co., Ltd.(Ireland) 製造的Lipitor價格
  • Pfizer Co., Ltd. (the U.S.A.) 製造的Lipitor價格
  • 價格
  • Pfizer Inc (Germany)的Lipitor價格

第7章 中國的主要Atorvastatin製造商分析

  • Ebang Pharmaceutical
  • Pfizer
  • Topfond
  • Beijing Jialin Pharmaceutical Co., Ltd.

第8章 中國的Atorvastatin市場展望

  • 市場規模預測
  • 競爭格局預測

主要表(圖表)

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1506206

With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the near future.

Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly 20 years of use in over 100 countries in the real world, atorvastation has proved its efficacy and safety in hundreds of clinical tests and hundreds of millions of clinical medications. Large amounts of evidences and clinical practices have confirmed that atorvastation (10-80 mg) has strong effects in reducing low-density lipoprotein cholesterol (LDL-C). For patients with coronary heart disease, ischemic stroke, diabetes and hypertension, atorvastation is proved to reduce the number of cases of major cardiovascular diseases safely. By the end of 2014, the sales value of atorvastation has surpassed USD 100 billion around the world, creating a fabulous miracle among all the medicines for sale.

After entering China, atorvastatin develops fast with annual sales value rising from less than CNY 70 million in 2005 to CNY 1.374 billion in 2014 and CAGR reaching up to 41% during 2005-2014. Atorvastatin enjoys a vast demand in China. And such companies as Pfizer Inc (Ireland), Pfizer Inc (the US), Topfond and Beijing Jialin Pharmaceutical Co., Ltd occupy the market, among which Pfizer (the US) has the largest market share of about 65% in 2014 with sales value reaching up to CNY 895 million.

As the number of hyperlipidemia patients keeps growing, the sales value of atorvastatin is expected to increase in the next few years.

Readers can get at least the following information from this report:

  • sales status of atorvastatin in China
  • price of atorvastatin in Chinese market
  • major manufacturers of atorvastatin in Chinese market
  • share of dosage forms of atorvastatin in China
  • market outlook of atorvastatin in China

The author suggests the following groups of people purchase this report:

  • manufacturers of cardiovascular drugs
  • investors/ research institutions interested in China cardiovascular drug market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Atorvastatin

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Atorvastatin in China

  • 2.1. Patent and Approval Status of Atorvastatin in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Atorvastatin in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Atorvastatin in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Atorvastatin in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Atorvastatin in Chinese Hospitals in 2014

  • 6.1. Beijing Jialin Pharmaceutical Co., Ltd (Trade Name: A Le)
  • 6.3. Topfond (Trade Name: You Jia)

6.4Pfizer Inc (Ireland) (Trade Name: Lipitor)

  • 6.5. Pfizer Inc(the US) (Trade Name: Lipitor)
  • 6.6. Pfizer Inc (Germany) (Trade Name: Lipitor)

7. Major Manufacturers of Atorvastatin in Chinese Market , 2010-2014

  • 7.1. Ebang Pharmaceutical
  • 7.2. Pfizer Inc
  • 7.3. Topfond
  • 7.4. Beijing Jialin Pharmaceutical Co., Ltd

8. Market Outlook of Atorvastatin in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Atorvastatin in China
  • Chart Approval Information of Atorvastatin in China
  • Chart Sales Status of Atorvastatin in China
  • Chart Sales Value of Atorvastatin in China, 2010-2014
  • Chart Sales Value of Atorvastatin in Some Regions in China, 2010-2014
  • Chart Sales Volume of Atorvastatin in China, 2010-2014
  • Chart Market Share of TOP4 Manufacturers of Atorvastatin for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Made by Pfizer (the US) in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Made by Beijing Jialin in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Made by Pfizer (Ireland) in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Made by Topfond in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Tablets in China, 2010-2014
  • Chart Sales Value and Market Share of Atorvastatin Capsules in China, 2010-2014
  • Chart Price of Atorvastatin Made by Beijing Jialin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Atorvastatin Made by Topfond in Some Chinese Cities in 2014
  • Chart Price of Atorvastatin Made by Pfizer Inc (IR) in Some Chinese Cities in 2014
  • Chart Price of Atorvastatin Made by Pfizer Inc (the US) in Some Chinese Cities in 2014
  • Chart Price of Atorvastatin Made by Pfizer Inc (Germany) in Some Chinese Cities in 2014
Back to Top